Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic review.


AIM This systematic review summarizes the clinical data on focal therapy (FT) when used alone as definitive therapy for primary prostate cancer (PCa). METHODS The protocol is detailed in the online PROSPERO database, registration No. CRD42014014765. Articles evaluating any form of FT alone as a definitive treatment for PCa in adult male patients were… (More)
DOI: 10.2217/fon-2016-0354


  • Presentations referencing similar topics